USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

v2.5.0

Opposition

Defendant
Name:	Biocytogen Pharmaceuticals (Beijing) Co.
Correspondence:	CYNTHIA JOHNSON WALDEN FISH & RICHARDSON P.C. P.O. BOX 1022 MINNEAPOLIS, MN 55440-1022 UNITED STATES tmdoctc@fr.com, mccormick@fr.com, walden@fr.com, kelleher@fr.com, rsmith@fr.com Phone: 617-542-5070

Serial #:	88553807	Application File	Assignment
Application Status:	OPPOSITION PENDING
Mark:	RENMAB

Plaintiff
Name:	Genmab A/S
Correspondence:	MARK LERNER DUANE MORRIS LLP 230 PARK AVENUE, SUITE 1130 NEW YORK, NY 10169 UNITED STATES malerner@duanemorris.com, trademarks@duanemorris.com Phone: 212-404-8714

Serial #:	76105834	Application File	Assignment	Registration #:	2850023
Application Status:	REGISTERED AND RENEWED
Mark:	GENMAB


Serial #:	79040923	Application File	Assignment	Registration #:	3431559
Application Status:	SECTION 71 ACCEPTED
Mark:	GENMAB

Prosecution History
#	Date	History Text	Due Date
22	04/09/2024	SUSPENDED
21	02/14/2024	MOT TO AMEND APPLICATION
20	11/16/2023	EXTENSION OF TIME GRANTED
19	11/16/2023	P MOT FOR EXT W/ CONSENT
18	08/21/2023	EXTENSION OF TIME GRANTED
17	08/21/2023	P MOT FOR EXT W/ CONSENT
16	05/15/2023	EXTENSION OF TIME GRANTED
15	05/15/2023	P MOT FOR EXT W/ CONSENT
14	03/14/2023	SUSPENDED
13	03/14/2023	P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
12	12/19/2022	SUSPENDED
11	12/19/2022	P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
10	09/21/2022	SUSPENDED
9	09/21/2022	P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
8	07/14/2022	EXTENSION OF TIME GRANTED
7	07/14/2022	P MOT FOR EXT W/ CONSENT
6	04/20/2022	SUSPENDED
5	04/20/2022	P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
4	03/28/2022	ANSWER
3	02/14/2022	INSTITUTED
2	02/14/2022	NOTICE AND TRIAL DATES SENT; ANSWER DUE:	03/26/2022
1	02/14/2022	FILED AND FEE